Zobrazeno 1 - 10
of 26
pro vyhledávání: '"T C, Greiner"'
Autor:
Giorgio Inghirami, Fabio Facchetti, Santiago Montes-Moreno, Ken H. Young, Cassio P. de Campos, Emanuele Zucca, Marta Scandurra, Francesco Bertoni, Annalisa Chiappella, Graziella Pinotti, Michael Mian, Silvia Uccella, Ivo Kwee, Miguel A. Piris, Gianluca Gaidano, Thierry Lazure, Maria Grazia Tibiletti, Wing C. Chan, Andrea Rinaldi, Olivier Lambotte, Julie M. Vose, Silvia Franceschetti, Paola M.V. Rancoita, Giovanni Martinelli, Andrés J.M. Ferreri, Giancarlo Pruneri, Alessandra Tucci, Luca Baldini, Josep F. Nomdedeu, Ekaterina Chigrinova, Maurilio Ponzoni, T. C. Greiner
Publikováno v:
British Journal of Haematology. 151:221-231
Despite recent therapeutic improvements, the clinical course of diffuse large B-cell lymphoma (DLBCL) still differs considerably among patients. We conducted this retrospective multi-centre study to evaluate the impact of genomic aberrations detected
Autor:
T. C. Greiner, Andreas Rosenwald, E. S. Jaffe, Montserrat E, Xavier Puig, Liming Yang, Joseph M. Connors, Jan Delabie, Itziar Salaverria, Christof Burek, Rita M. Braziel, James O. Armitage, George Wright, Wing C. Chan, Wyndham Wilson, Thomas M. Grogan, Philipp Jehn, Louis M. Staudt, H.K. Müller-Hermelink, Victor Moreno, Armando López-Guillermo, Sílvia Beà, Elias Campo, Richard I. Fisher, Harald Holte, Stein Kvaløy, John Powell, Dennis D. Weisenburger, Andreas Zettl, Erlend B. Smeland, Randy D. Gascoyne, German Ott, Simon Rm
Publikováno v:
Blood. 106:3183-3190
Gene-expression profiling has identified 3 major subgroups of diffuse large B-cell lymphoma (DLBCL): germinal center B-cell-like (GCB), activated B-cell-like (ABC), and primary mediastinal DLBCL (PMBCL). Using comparative genomic hybridization (CGH),
Autor:
I. A. Auer, T. C. Greiner, Randy D. Gascoyne, J. M. Conners, Douglas E. Horsman, Warren G. Sanger, F. E. Cotter
Publikováno v:
Annals of Oncology. 8:979-985
Summary Background Low grade malignant lymphomas arising from mucosa associated lymphoid tissue (MALT) represent a distinct clinicopathological entity. The cytogenetic findings and molecular genetics of MALT lymphomas remain minimally defined. Cytoge
Autor:
Robert Rifkin, Julie M. Vose, Alan Norman Langnas, B. N. Smir, T. C. Greiner, Philip J. Bierman, Ralph J. Hauke
Publikováno v:
Annals of Oncology. 7:265-270
Summary Background: The incidence of second malignancies is markedly increased following transplantation of solid organs. However, the development of Hodgkin's disease has been described relatively infrequently in this setting, and there is little cl
Autor:
T. C. Greiner, M. R. Abell, George D. Lundberg, K. M. Ireland, P. L. Barney, J. W. Green, J. S. Abercrombie, P. J. Cherney, R. A. Dietrich, R. B. Conn, E. S. Tucker, M. D. Burke, R. W. Christie, C. B. Cook, R. E. Horowitz, P. S. Cathcart, D. A. Senhauser, A. R. Graham
Publikováno v:
American Journal of Clinical Pathology. 98:257-267
Autor:
Wing C. Chan, Michael Boe Møller, James S. Malter, Corinne Haioun, William M. Rehrauer, Elaine S. Jaffe, Randy D. Gascoyne, Miguel A. Piris, Fabio R. Kerbauy, Lisa M. Rimsza, Elias Campo, Terry D. Oberley, Gisele Wb Colleoni, Andreas Rosenwald, Ken H. Young, Margarita Sánchez-Beato, Brad S. Kahl, James Z. Huang, Dennis D. Weisenburger, Louis M. Staudt, T. C. Greiner, Allen H. Young, Wyndham H. Wilson, Jan Delabie, Jens C. Eickhoff, Rita M. Braziel, Julie M. Vose, Philippe Gaulard, Karen Leroy
Publikováno v:
Young, K H, Leroy, K, Møller, M B, Colleoni, G WB, Sanchez-Beato, M, Kerbauy, F R, Haioun, C, Eickhoff, J C, Young, A H, Gaulard, P, Piris, M A, Oberley, T D, Rehrauer, W M, Kahl, B S, Malter, J S, Campo, E, Delabie, J, Gascoyne, R D, Rosenwald, A, Rimsza, L, Huang, J, Braziel, R M, Jaffe, E S, Wilson, W H, Staudt, L M, Vose, J M, Chan, W C, Weisenburger, D D & Greiner, T C 2008, ' Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma : an international collaborative study ', Blood . https://doi.org/10.1182/blood-2008-01-129783
The purpose of this study is to correlate the presence of TP53 gene mutations with the clinical outcome of a cohort of patients with diffuse large B-cell lymphoma (DLBCL) assembled from 12 medical centers. TP53 mutations were identified in 102 of 477
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65fb59906cc56a4addc630e08156a9fc
https://portal.findresearcher.sdu.dk/da/publications/9484a870-4676-11dd-9fbe-000ea68e967b
https://portal.findresearcher.sdu.dk/da/publications/9484a870-4676-11dd-9fbe-000ea68e967b
Autor:
A, Abou-Elella, M T, Shafer, X Y, Wan, M, Velanker, D D, Weisenburger, B N, Nathwani, R D, Gascoyne, T C, Greiner, W C, Chan
Publikováno v:
American journal of clinical pathology. 114(4)
We investigated the clonal relationship between follicular center cell and monocytoid B-cell components of non-Hodgkin lymphoma by isolating the components and comparing the nucleotide sequences of the complementarity-determining region (CDR)3 of the
Autor:
D D, Weisenburger, J M, Vose, T C, Greiner, J C, Lynch, W C, Chan, P J, Bierman, B J, Dave, W G, Sanger, J O, Armitage
Publikováno v:
American journal of hematology. 64(3)
Although mantle cell lymphoma (MCL) is considered a distinctive disease entity within non-Hodgkin's lymphoma (NHL), the cytology and growth pattern of MCL can be quite variable and the clinical significance of these features is unclear. Also, the rol
Publikováno v:
Blood. 95(5)
Diffuse large B-cell lymphoma (DLBCL) is a common type of non-Hodgkin's lymphoma (NHL) that is highly heterogeneous from both clinical and histopathologic viewpoints. The immunoglobulin (Ig) heavy (H) chain variable region genes were examined in 71 p
Autor:
R D, Gascoyne, P, Aoun, D, Wu, M, Chhanabhai, B F, Skinnider, T C, Greiner, S W, Morris, J M, Connors, J M, Vose, D S, Viswanatha, A, Coldman, D D, Weisenburger
Publikováno v:
Blood. 93(11)
Anaplastic large cell lymphoma (ALCL) is an aggressive lymphoma that is frequently associated with the t(2;5)(p23;q35), resulting in expression of a fusion protein, nucleophosmin-anaplastic lymphoma kinase (NPM-ALK), which can be detected by either m